ECOR - Bullish In Force - Possible 20% Move Due.

6 sept 2019

electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.

SHORT INTEREST
1.47M 08/15/19

P/E Current
-1.87

P/E Ratio (with extraordinary items)
-1.20

Average Recommendation: OVERWEIGHT

Average Target Price: 10.50